Document
type: Class

Celecoxib enhances the detoxification of diethylnitrosamine in rat liver cancer
type: Generically Dependent Continuant
estado: published
type: Information Content Entity
related by: authorship_13641
abstract: Aim: To study the effect of celecoxib (CXB) on diethylnitrosamine activation through the regulation of cytochrome P450 in a hepatocarcinogenesis model. Methods: Six-week-old male Sprague-Dawley rats were randomly divided into five groups, a non-treated group (NT), a diethylnitrosamine-treated group (DEN), a DEN CXB-treated group (DEN CXB), and CXB 8 d-treated and CXB 32 d-treated groups. The effects of celecoxib on the enzymatic activities of CYP1A1, 2A, 2B1/2, and 2E1 were assessed in hepatic microsomes 24 h after DEN administration. Changes in CYP1A1 and CYP2B1/2 protein expression were also evaluated. The rate of DEN metabolism was measured by the production of the deethylation metabolite acetaldehyde, and the denitrosation metabolite nitrite. Results: DEN CXB administration produced a significant increase in the enzymatic activities of CYP2B1/2 and 1A1, whereas it did not change the activities of CYP2A and 2E1, compared to that of the DEN group. CXB treatment for eight days did not produce a significant effect on enzymatic activity when compared to the NT group; however, when it was administered for prolonged times (CXB 32 d group), the enzymatic activities were increased in a similar pattern to those in the DEN CXB group. The observed increase in the enzymatic activities in the DEN CXB group was accompanied by an increase in the CYP2B1/2 protein levels; no changes were observed in the levels of CYP1A1. In vitro, CXB increased the denitrosation of DEN, a pathway of metabolic detoxification. The addition of SKF-525A, a preferential inhibitor of CYP2B, abrogated the denitrosation of DEN. Conclusion: These results suggest that the mechanism of action of CXB involves enhancement of the detoxification of DEN by an increasing denitrosation via CYP2B1/2. © 2009 The WJG Press and Baishideng. All rights reserved.
accesstype: All Open Access, Hybrid Gold, Green
issue: 19
related by: authorship_13644
type: Article
freetext keyword: Celecoxib; Chemoprevention; Cytochromes P450; Denitrosation; Diethylnitrosamine; Hepatocarcinogenesis acetaldehyde; celecoxib; cytochrome P450 1A1; cytochrome P450 2A; cytochrome P450 2B1; cytochrome P450 2B2; cytochrome P450 2E1; diethylnitrosamine; nitrite; proadifen; animal experiment; animal model; article; cancer model; cancer prevention; controlled study; detoxification; drug efficacy; drug mechanism; drug protein binding; enzyme activity; enzyme inhibition; enzyme regulation; in vitro study; liver cancer; liver microsome metabolism; long term care; male; nonhuman; protein expression; rat; Sprague Dawley rat; treatment duration; Animals; Aryl Hydrocarbon Hydroxylases; Cyclooxygenase Inhibitors; Diethylnitrosamine; Liver Neoplasms, Experimental; Male; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides
most specific type: Article
date time value: article date 2299
tradenames: celebrex, Pfizer, Mexico
type: Thing
most specific type: Document
has publication venue: World Journal of Gastroenterology
related by: authorship_13642
manufactures: Pfizer, Mexico
page end: 2350
related by: authorship_13645
page start: 2345
chemicalscas: acetaldehyde, 75-07-0; celecoxib, 169590-42-5; cytochrome P450 2B1, 330207-10-8; cytochrome P450 2B2, 331462-97-6; diethylnitrosamine, 55-18-5; nitrite, 14797-65-0; proadifen, 302-33-0, 62-68-0; Aryl Hydrocarbon Hydroxylases, 1.14.14.1; Cyclooxygenase Inhibitors; Diethylnitrosamine, 55-18-5; Pyrazoles; Sulfonamides; celecoxib, 169590-42-5
pmid: 19452576
doi: 10.3748/wjg.15.2345
origen: scopus
type: Continuant
related by: authorship_13643
crisid: 2299
type: Entity
type: Document
e iscopus: 2-s2.0-67651247837
volume: 15
abstract: Aim: To study the effect of celecoxib (CXB) on diethylnitrosamine activation through the regulation of cytochrome P450 in a hepatocarcinogenesis model. Methods: Six-week-old male Sprague-Dawley rats were randomly divided into five groups, a non-treated group (NT), a diethylnitrosamine-treated group (DEN), a DEN%2bCXB-treated group (DEN%2bCXB), and CXB 8 d-treated and CXB 32 d-treated groups. The effects of celecoxib on the enzymatic activities of CYP1A1, 2A, 2B1/2, and 2E1 were assessed in hepatic microsomes 24 h after DEN administration. Changes in CYP1A1 and CYP2B1/2 protein expression were also evaluated. The rate of DEN metabolism was measured by the production of the deethylation metabolite acetaldehyde, and the denitrosation metabolite nitrite. Results: DEN%2bCXB administration produced a significant increase in the enzymatic activities of CYP2B1/2 and 1A1, whereas it did not change the activities of CYP2A and 2E1, compared to that of the DEN group. CXB treatment for eight days did not produce a significant effect on enzymatic activity when compared to the NT group; however, when it was administered for prolonged times (CXB 32 d group), the enzymatic activities were increased in a similar pattern to those in the DEN%2bCXB group. The observed increase in the enzymatic activities in the DEN%2bCXB group was accompanied by an increase in the CYP2B1/2 protein levels; no changes were observed in the levels of CYP1A1. In vitro, CXB increased the denitrosation of DEN, a pathway of metabolic detoxification. The addition of SKF-525A, a preferential inhibitor of CYP2B, abrogated the denitrosation of DEN. Conclusion: These results suggest that the mechanism of action of CXB involves enhancement of the detoxification of DEN by an increasing denitrosation via CYP2B1/2. © 2009 The WJG Press and Baishideng. All rights reserved.

Continuant
type: Class

Entity
type: Class

Generically Dependent Continuant
type: Class

RDF description of Celecoxib enhances the detoxification of diethylnitrosamine in rat liver cancer - http://orbis.uaslp.mx/vivo/individual/scopus2298
rights: termsOfUse
date: 2026-08-25T01:05:06
publisher: vivo
type: Document

Article
type: Class

World Journal of Gastroenterology
type: Collection
publication venue for: Celecoxib enhances the detoxification of diethylnitrosamine in rat liver cancer
type: Periodical
type: Journal
type: Entity
type: Continuant
type: Thing
type: Information Content Entity
type: Generically Dependent Continuant
type: Document

Information Content Entity
type: Class